Company intelligence / Profile preview

Poriferous

Ownership: Private
Employees: ~19
Development stage: Other

Overview

Poriferous manufactures and markets Su-Por Surgical Implants—porous high-density polyethylene devices cleared by the FDA and other regulatory bodies for long-term implantation in craniomaxillofacial applications. Clinical evidence supports superior integration and infection resistance compared to non-integrating alternatives. The company has a global presence with ongoing innovation in implant design.

Therapeutic areas: Other
Modalities: Device (Surgical implant)Polymer-based medical device (Porous high-density polyethylene)
Industry: Implantable Medical Devices

Partnerships

Minogue Medical Inc. (exclusive Canadian distributor)

Beyond the preview

Go deeper on Poriferous.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poriferous.

Explore the full profile